Bibliografia UJ CM

1/4
Jorge E. Cortes, Jane Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey Howard Lipton, Charles Schiffer, James K. McCloskey, Andreas Hochhaus, Philippe H. Rousselot, Gianantonio Rosti, Hugues de Lavallade, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael W. Deininger.
OPTIC primary analysis : a dose-optimization study of 3 starting doses of ponatinib (PON).
Journal of Clinical Oncology
2021 : Vol. 39, nr 15 suppl., abstr. 7000
2021 ASCO Annual Meeting I.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
SZZ
SIF
Adres url:
DOI:
2/4
Jorge Cortes, Jane F. Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, Charles A. Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Arthur, Lori J. Maness, Moshe Talpaz, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael W. Deininger.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia : a randomized, open-label phase 2 clinical trial.
Blood
2021 : Vol. 138, nr 21, s. 2042-2050
Auto korespondencyjny: Jorge Cortes.
p-ISSN: 0006-4971
e-ISSN: 1528-0020
AZ
ORG
AIF
IF: 25.669
Adres url:
Streszczenie w PubMed:
DOI:
3/4
Francois-Xavier Mahon, Carla Boquimpani, Naoto Takahashi, Noam Benyamini, Nelma Cristina D. Clementino, Vasily Shuvaev, Jeffrey H. Lipton, Anna G. Turkina, Raquel De Paz Arias, Beatriz Moiraghi, Franck E. Nicolini, Jolanta Dengler, Tomasz Sacha, Dong-Wook Kim, Rafik Fellague-Chebra, Ranjan Tiwari, Catherine Bouard, Timothy P. Hughes.
ENESTop 192-Weeks Results : Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.
Clinical Lymphoma, Myeloma and Leukemia
2019 : Vol. 19, suppl. 1, s. S288-S289, abstr.
p-ISSN: 2152-2650
SZZ
SIF
Adres url:
4/4
François-Xavier Mahon, Carla Boquimpani, Dong-Wook Kim, Noam Benyamini, Nelma Cristina D. Clementino, Vasily Shuvaev, Sikander Ailawadhi, Jeffrey Howard Lipton, Anna G. Turkina, Raquel De Paz, Beatriz Moiraghi, Franck E. Nicolini, Jolanta Dengler, Tomasz Sacha, Naoto Takahashi, Rafik Fellague-Chebra, Sandip Acharya, Stephane Wong, Yu Jin, Timothy P. Hughes.
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Annals of Internal Medicine
2018 : Vol. 168, nr 7, s. 461-470
Autor korespondencyjny: Timothy P. Hughes.
p-ISSN: 0003-4819
AZ
ORG
AIF
IF: 19.315
Adres url:
Streszczenie w PubMed:
DOI:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ